Icentia LLC

Icentia is a medical devices manufacturer and service company specializing in innovative solutions for long-term cardiac monitoring and ECG testing in institutional healthcare settings. The company's flagship product is CardioSTAT®, a compact, lightweight, and patient-comfortable continuous ECG recorder designed for ambulatory cardiac rhythm diagnosis. CardioSTAT features high-quality single-lead ECG recordings optimized for extended wear, combining clinical accuracy with superior patient compliance. The device has achieved FDA clearance in the United States and is used extensively across Canadian academic medical centers and cardiac institutes. Icentia has established partnerships with leading academic institutions including Institut Universitaire de Cardiologie et de Pneumologie de Québec, Institut de Cardiologie de Montréal, Ottawa Heart Institute, and Hamilton Health Sciences. The company has demonstrated significant growth, ranking among Canada's top growing companies for four consecutive years (2019–2022). Icentia maintains robust data collection and analysis capabilities, having compiled the largest public single-lead ECG dataset of 11,000 patients with 2 billion annotated beats. The CardioSTAT system has surpassed 100,000 completed tests, establishing clinical credibility in arrhythmia detection and continuous cardiac monitoring. The company operates as both a device manufacturer and service provider, leveraging partnerships with research institutions including Mila (Montreal Institute for Learning Algorithms). Icentia serves institutional healthcare markets across North America with a focus on cardiac diagnostic excellence and clinician-friendly workflow integration.